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fasalazine, Multi-Matrix System mesalamine [MMX], balsalazide disodium, mesa-
lamine delayed release [MDR]) during 2007-2011. Patients were continuously en-
rolled in the 6-month pre- and 12-month post-initiation period. 5-ASA treatment
persistence and adherence according to the initial prescription filled (index medi-
cation) were compared. Persistence was defined as the duration between initiation
and discontinuation of therapy with a permissible gap 60 days, and analyzed
using Kaplan-Meier survival analysis. Persistence rates at month 12 were calcu-
lated. Adherence was measured by medication possession ratio (MPR) for index
drug, and proportion of days covered (PDC) for any 5-ASA. Analysis of covariance
was used to compare MPR and PDC across index medication. Covariates included
age, gender, insurance, residential region, comorbidities at index date, and use of
immunosuppressive/biologic agents, rectal form of 5-ASA and access to specialist
care post 12-month index date. RESULTS: A total of 5245 patients met selection
criteria, 59% were on MDR, 17% MMX, 13% sulfasalazine, and 11% balsalazide. The
median persistence days ranged from 151 [sulfasalazine] to 221 [MMX] days,
P0.001). Persistence rates at month 12 was highest for MMX (28%) compared to
other 5-ASAs (24% MDR, 23% balsalazide, and 20% sulfasalazine, respectively,
logrank P0.001). Mean adjusted MPR/PDC  standard error was significantly
higher in the patients on MMX (0.480.02/0.530.02) than that of patients on other
5-ASAs (0.430.01/0.500.01 [MDR], 0.430.02/0.490.02 [balsalazide], and
0.390.02/0.470.02 [sulfasalazine], P0.01/P0.04). CONCLUSIONS: Patients on
once-daily MMX were significantly more persistent and adherent with UC treat-
ment than those on other 5-ASA index drugs although persistence and adherence
with oral 5-ASAs in UC patients were suboptimal.
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OBJECTIVES: Our previous study suggested that Taiwan’s drug price adjustments
result in prescription switching from cheaper angiotensin-converting enzyme in-
hibitors (ACEIs) to expensive angiotensin receptor blockers (ARBs), demonstrated
by a macro level data that showed a decrease use in ACEIs and an increase use in
ARBs after policy implementation and by a long-term increasing trend observed in
annual prevalent ARB users that exceeded the cumulative incident ARB users. This
study uses individual patient level data to examine the proportions of prescription
switching from ACEIs to ARBs among the prevalent ARB users. METHODS: We
identified 82,447 patients treated with ARBs between Feb 1998 and Dec 2008 from
Taiwan’s Longitudinal Health Insurance Database (LHID2005). We examined the
monthly prevalent users of ARBs (from 2/1998 - 12/2008), the incident users of ARBs
(who receive ARBs first time in a givenmonth fromFeb 1998 to Dec 2008 and did not
receive ACEIs or ARBs in the preceding months from 1997 to 2008), and the ACEIs-
to-ARBs switchers (who used ARBs in a given month and used ACEIs or both drugs
[ACEIs in combinationwith ARBs] in lastmonth during 2/1998 - 12/2008). RESULTS:
The number of monthly prevalent ARB users increased from 4 to 32,292 from Fe-
burary 1998 to December 2008. The growth of ARB prevalent users was mainly
contributed by the incident ARB users and the ACEIs-to-ARBs switchers. The num-
ber of monthly incident ARB users increased from 2 to 562 and that of monthly
ACEIs-to-ARBs switchers increased from 1 to 477 from February 1998 to December
2008. The number of ACEIs-to-ARBs switchers exceeds that of incident ARB users
(averagemonthly ratio of the former to the latter is 1.25). CONCLUSIONS: Prescrip-
tion switching from cheaper ACEIs to expensive ARBs based on individual patient
level data is evident. Policy makers should be aware of this problem.
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OBJECTIVES: To evaluate the extent towhich racial and ethnic disparities in health
care utilization persist longitudinally. METHODS: We analyzed data from 2008 to
2010 National Health Interview Survey (NHIS) in the United States to examine
insurance status and utilization of health care based on race/ethnicity (non-His-
panic White, Hispanic White, Black, Asian, and others). We used two outcome
measures to define utilization of health care: at least one physician visit every two
weeks, and the average number of physician visits every twoweeks.We performed
multiple linear regression and logistic regression with sampling weight adjust-
ments for data analysis, stratified by dichotomous insurance status. Survey re-
spondents with private or public insurance or both were considered insured; oth-
erwise uninsured. All analyses were adjusted for age, education, gender, income-
to-poverty ratio, self-reported health status, and activity limitation. RESULTS:
Overall, insured rates decreased from 2008 to 2010 and the decreasing rate was
significantly associated with race/ethnicity (p0.01). Particularly, Asian had a
faster decreasing rate comparedwith non-Hispanicwhite (p0.05). The probability
of having at least one physician visit every two weeks for insured adults slightly
increased during 2008 and 2010, and was not significantly associated with race/
ethnicity. However, insured HispanicWhite and Asian Americans were still signif-
icantly less likely to have at least one physician visit every two weeks in compar-
ison to non-HispanicWhite (p0.05). The average number of physician visits every
two weeks for insured adults was significantly associated with year and race/eth-
nicity (p0.01). Both outcome measures did not significantly change from 2008 to
2010 for uninsured adults. CONCLUSIONS: Reducing racial and ethnic disparities is
an important priority in the United States. The results from NHIS show such dis-
parities in health care utilization persist regardless of insurance status. More stud-
ies are needed to identify other factors associated with such disparities.
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OBJECTIVES: To identify the rate of patient’s prescription filling in outpatient
health care departments in Indonesia, and to examine its related factor.
METHODS: Secondary data from the 4thWave Indonesia Family Life Survey (IFLS,
RAND Corp.) were used to obtain the Indonesia patients socio-economic charac-
teristics including their behavior on filling prescription in outpatient health care
departments. Factors related to prescription filling were identified from similar
studies such as educational level, economic status, geographical status (urban-
village, mainland-based), health insurance coverage, catastrophic health care
costs, satisfaction from health care received, andmorbidity (days of illness, illness
condition). Statistical analyses such as univariate, bivariate, andmultivariate anal-
yses were performed in a cross-sectional study to identify and to examine the
relationship between those factors with prescription filling rate. Meanwhile, inter-
action test also performed among variables in the multivariate model. RESULTS:
Six hundred forty-one respondent data were eligible and used for analysis pur-
poses. Results showed that 85,49% patients from outpatient health care depart-
ment filled their prescriptions. Bivariate analysis showed that factors related to the
prescription filling rate were educational level (p0,031), economic status
(p0,085), geographical status (p0,016 for urban-village, p0,000 for mainland-
based), and catastrophic outpatient health care costs (p0,060). Meanwhile, mul-
tivariate analyses showed that only geographical status (p 0,019 for urban-village)
was significant. In terms of geographical status, patients who lived in Java Island
had 1,6 times greater possibilities in prescription filling compared to patients who
lived in other islands. No interaction identified between variables in the last mul-
tivariate model. CONCLUSIONS: Prescription filling in the outpatient health care
department can be considered not optimum. Policy to enhance prescription filling
in outpatient health care department should put an emphasize on geographical
conditions of Indonesia which consists of thousand islands.
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OBJECTIVES: Providers of a new technology are increasingly obliged to give gov-
ernments an insight into related costs and benefits, and its value for money. This
necessitates the use of cost-effectiveness (CEA) and cost-utility data. A good health
policy, however,must not only aim to be efficient but should also guarantee equity.
METHODS: An analytic model has been developed to assess the ability to pay for
128 countries. The method introduces proportionality into pricing and reimburse-
ment decisions across and within Asia Pacific countries by taking into account
purchasing power paritymeasured at either the national or household level. Value-
based pricing techniques are used in combination with national income parame-
ters as defined in the Human Development Index together with health system
variables. The resulting non-linear equity curve is a graphic representation of a
price index calculated based on a country’s national income. The ratio of wealth
inversely reflects the theoretical discount rate that can be applied to each country
compared to a high income reference country. The steepest discounts are reserved
for the poorest countries, while for middle and high-income countries discounts
will decrease as the country’s wealth increases. RESULTS: The degree to which
‘equitable pricing’ offers a sustainable solution to the problem of access to medi-
cines depends on: the economic development status of a country, the value of a
particular medicine to its therapeutic class and the incidence of the disease, and
the extent to which segmentation can be applied. CONCLUSIONS: Equitable, dif-
ferentiated pricing can improve access to and affordability of medicines, particu-
larly in low- and middle-income countries. The method is relevant for the Asia
Pacific region confronted with disparity in the ability-to-pay (ATP) between coun-
tries, and between different population segments in the same country.
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OBJECTIVES: Medicine Quality and accessibility are two of the main objectives of
health care systems. Pharmaceutical manufacturers have an important role to
meet these goals. But they are facedwith complicated environment and uncertain-
tieswhichcan affect ontheir performance and also accessibility andquality ofmed-
icines. Risk management is a new approach to assess and overcome these uncer-
tainties. In this study we have tried to identify, assess and make mitigation
strategies to manage risks which can affect on accessibility and quality of medi-
cines in three Iranian pharmaceutical companies.METHODS: First: The literatures
were reviewed for identification and categorization of potential risks. Second, a
semi-structured questionnaire was developed to get expert opinions about priori-
tization of risks andmitigations strategies. Third: the questionnaires were filled by
face to face interviewwith executive managers of three companies. RESULTS: Five
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